Related Experiment Video
Updated: Jun 25, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Group B streptococcal meningitis'clinical, biological and evolutive features in children]
E Georget-Bouquinet1, E Bingen, Y Aujard
1Service de réanimation polyvalente, Hôpital Kremlin Bicêtre. emilie.georget@chireteil.fr
Objective:
The group B streptococcal meningitis (GBS) remains an important cause of child's morbidity and mortality. The purposes of this work were to appreciate the GBS place among the bacterial meningitis, to define clinical and biological factors associated with death and to study the immediate complications.
Patients And Methods:
This study concerned 276 GBS meningitis listed by the observatory of GPIP/ACTIV on the child's bacterial meningitis in France from January, 2001 to December, 2005. This report is one of the biggest series of child's GBS meningitis published to this day.
Results:
The GBS was the third germ in frequency responsible for bacterial meningitis at every age (13 %) : 65 % of the GBS meningitis affected infants less than one month of age, 29 % infants between 1 month and 3 months of age and only 6 % infants more than 3 months of age. The male/female ratio in GBS meningitis was nearly equal (51 % vs 49 %). There was no variation of the GBS meningitis number according to the season. The serotype III was mostly involved in this cohort (81 %) followed by the serotype I (13 %). Statistically we observed a significant decline in the number of early onset meningitis from 2001 to 2004 whereas the number of late meningitis and the total meningitis cases were stable. The biological results mostly present in child's GBS meningitis were a high CSF protein level (95 %), a CSF neutrophil count more than fifteen percent (90 %), a low CSF glucose level (83.5 %), leukopenia (49 %) or a normal blood level leukocyte (38 %). Eighty three percent of the children affected by GBS meningitis were term infants. However, the prematurity seemed to be a risk factor to develop late meningitis (age between 7 days and 3 months) and very late meningitis (after 3 months) but no early onset meningitis. Prematurity, convulsions, shock, coma, assisted ventilation, high CSF protein level, weak CSF cell level and leukopenia seemed to be factors associated with death in the GBS meningitis. The mortality of the GBS meningitis was still 14 % and the immediate complications were observed in 62 % of cases, the most frequent being convulsions (45 %).
Conclusion:
The GBS meningitis in children remains a frequent problem in pediatrics despite intra partum antibioprophylaxy and thus must encourage to strengthen the prevention of these meningitis.
Insights
Group B Streptococcus (GBS) meningitis is a significant cause of infant illness and death. Despite prevention efforts, GBS meningitis remains a concern, necessitating stronger preventative strategies.
Area of Science:
- Pediatrics
- Infectious Diseases
- Bacteriology
Context:
- Group B Streptococcus (GBS) meningitis is a major cause of pediatric morbidity and mortality.
- This study analyzes 276 cases of GBS meningitis in children in France (2001-2005).
- It represents one of the largest published pediatric GBS meningitis cohorts.
Purpose:
- To determine the prevalence of GBS meningitis among bacterial meningitis cases.
- To identify clinical and biological factors associated with mortality.
- To describe immediate complications of GBS meningitis.
Summary:
- GBS was the third most frequent cause of bacterial meningitis (13%), predominantly affecting infants under one month (65%). Serotype III was most common (81%).
- Risk factors for death included prematurity, convulsions, shock, coma, ventilation, high CSF protein, low CSF cells, and leukopenia.
- Mortality was 14%, with 62% experiencing immediate complications, primarily convulsions (45%).
Impact:
- Highlights the continued public health challenge posed by GBS meningitis in children.
- Identifies key risk factors for mortality and complications, informing clinical management.
- Underscores the need for enhanced prevention strategies beyond intrapartum antibiotic prophylaxis.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Viral Meningitis
Streptococcal Pharyngitis
Cryptococcal Meningitis
